Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0000729 (abdominal cramps)
 531 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Thirty-two patients with advanced breast cancer were treated with mitomycin-C 10 mg/m2 IV and vinblastine 6 mg/m2 IV every 21 days in combination with lonidamine 450 mg/day P.O. and prednisone 15 mg/day P.O. given continuously. Among the 29 evaluable patients (all but three pretreated with an anthracycline-based regimen), one complete remission (CR) and six partial remissions (PR) (response rate, 24%) were seen. The median duration of response was 14 months (range, 4-30 months). Median survival for responders was 18 months (range, 4-30 months). Hematological toxicity was uncommon; the main lonidamine-related side effects were myalgia, abdominal cramps, and reversible deafness; these side effects were severe in two, one, and one patients, respectively. The regimen seems to have a reasonable degree of activity and toxicity in advanced, refractory breast cancer. The role of lonidamine in the treatment of this disease warrants further evaluation.
 ...
PMID:Mitomycin-C, vinblastine, and lonidamine as salvage treatment of advanced breast cancer. A pilot study. 212 16

A 59-year-old woman with a previous history of endometrial and breast cancer was referred to the colorectal rapid access clinic with abdominal cramps, per rectal bleeding and diarrhoea. CT, MRI and flexible sigmoidoscopy confirmed a rectal tumour and due to its appearance, it was thought to be a primary rectal malignancy. The patient underwent an anterior resection and end colostomy. Histology confirmed a metastatic endometrial adenocarcinoma, which is an unusual site for endometrial metastasis. Her postoperative recovery has been unremarkable and the patient has subsequently been discharged from the general surgical team.
...
PMID:Mistaken identity: endometrial or rectal cancer? 2484 36